Browsing Category

May 19, 2025

NHI To Expand Coverage Of PARP Inhibitors To More Cancer Types

Taipei: Taiwan’s health authority announced Monday that the National Health Insurance (NHI) coverage will be expanded for poly ADP-ribose polymerase (PARP) inhibitors to include other types of cancer treatments, effective from June 1. The expanded